卖什么
Curing cancer. Starting with dogs.
商业模式拆解
买家：谁掌握预算？
Owners of dogs with cancer (initially mast cell cancer, Australia) and referring veterinary oncologists.
触发点：什么让他们现在购买？
Dog diagnosed with cancer where surgery, chemotherapy or immunotherapy have not worked.
工作流：什么输入变成什么输出？
Review and intake, vet confirms diagnosis and ships tumour sample and matched blood to genomics lab, mutations analysed and personalised mRNA vaccine designed (~4 weeks), vet oncologist administers.
经济账：省了什么，怎么收费？
Pre-commercial; no price stated. Claims ~75% tumour reduction in first documented case and under 20 minutes of vet time for design review.
渠道：怎么接触到客户？
Vet referral form and owner interest registration; recruiting for an Australian trial.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-10-12 | — | $4M | — | news.google.com |
| — | YC 2026 夏季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-17.